Complementary treatments: Nitric oxide, prone positioning and surfactant;Tratamientos complementarios: Óxido nítrico, posición en prono y surfactante

Anales de Pediatria

Volumn 59, Issue 5, 2003, Pages 483-490

  Martos Sanchez I ^a   Vazquez Martinez J L ^a   Otheo De Tejada, E ^a   Ros, P ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Acute respiratory distress syndrome; Hypoxemic respiratory failure; Nitric oxide; Prone positioning; Surfactant Children

Indexed keywords

LUNG SURFACTANT; NITRIC OXIDE; VASODILATOR AGENT;

BODY POSTURE; CONGENITAL HEART DISEASE; DISEASE ASSOCIATION; HUMAN; HYALINE MEMBRANE DISEASE; HYPOXIA; LUNG ARTERIOVENOUS SHUNT; LUNG INJURY; LUNG VENTILATION; MORTALITY; NEWBORN; OXYGEN TRANSPORT; OXYGENATION; PREMATURITY; PROGNOSIS; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY FAILURE; REVIEW; TREATMENT OUTCOME; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CHILD; HYPOXEMIA; INFANT; NEONATAL RESPIRATORY DISTRESS SYNDROME; PRACTICE GUIDELINE;

ADULT; ANOXEMIA; CHILD; HUMANS; INFANT; INFANT, NEWBORN; NITRIC OXIDE; PRONE POSITION; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 85047104288     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1695-4033(03)78764-5     Document Type: Article

References (31)

1. Francoe M, Troncy E, Blaise G. Inhaled nitric oxide. Technical aspects of administration and monitoring. Crit Care Med 1998;26:782-96.
2. Finer NN, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term (Cochrane Review). The Cochrane Library, Issue 2, 2002.
3. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, et al. For the Clinical Inhaled Nitric Oxide Research Group. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med 2000;342:469-74.
4. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled Nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997;336:597-604.
5. American Academy of Pediatrics. Committee on Fetus and Newborn. Use of Inhaled Nitric Oxide. Pediatrics 2000;106:344-5.
6. Dellinger RP, Zimmerman JL, Taylor RW, Straube RC. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial. Crit Care Med 1998;26:15-23.
7. Bloomfield GL, Holloway S, Ridings PC, Fisher BJ, Blocher CR, Sholley M, et al. Pretreatment with Inhaled Nitric Oxide inhibits neutrophil migration and oxidative activity resultin in attenuated sepsis-induced acute lung injury. Crit Care Med 1997;25:584-93.
8. Sokol J, Jacobs SE, Bohn D. Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults (Cochrane Review). The Cochrane Library, Issue 2, 2002.
9. López-Herce Cid J, Cueto Calvo E, Carrillo Alvarez A, Vázquez P, Bustinza A, Moral R. Respuesta aguda a la administració n de óxido nítrico en niños. An Esp Pediatr 1997;46:581-6.
10. Day RW, Guarin M, Lynch JM, Vernon DD, Dean JM. Inhaled nitric oxide in children with severe lung disease: Results of acute and prolonged therapy with two concentrations. Crit Care Med 1996;24:215-21.
11. Troncy E, Collet JP, Shapiro S. Inhaled nitric oxide in acute respiratory distress syndrome: A pilot randomized controlled study. Am J Respir Crit Care Med 1998;157:1483-8.
12. Beghetti M, Habre W, Friedli B, Berner M. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paedatric patients. Br Heart J 1995;73:65-8.
13. Schulze-Neick I, Bultmann M, Werner H, Gamillscheg A, Vogel M, Berger F, et al. Right ventricular function in patients treated with inhaled nitric oxide after cardiac surgery for congenital Heart disease in newborn and children, Am J Cardiol 1997;80:360-3.
14. Njohnston SJ, Falkos SA, Gómez RJ, Morris A. Life-treatening status asthmaticus treated with inhaled nitric oxide. J Pediatr 2000;137:119-22.
15. Cueto E, López-Herce J, Sánchez A, Carrillo A. Life-threatening effects of discontinuing inhaled nitric oxide in children. Acta Paediatr 1997;86:1337-9.
16. Bichel T, Spahr-Schopfer I, Berner M, Jaeggi E, Velkovski Y, Friedli B, et al. Successful weaning from cardiopulmonary bypass after cardiac surgery using inhaled nitric oxide. Paediatr Anaesth 1997;7:335-9.
17. Lee DL, Chiang HT, Lin SL, Ger LP, Kun MH, Huang YC. Prone-position ventilation induces sustained improvement in oxygenation in patients with acute respiratory distress syndrome who have a large shunt. Crit Care Med 2002;30:1446-52.
18. Gattinoni L, Tognoni G, Pesenti A, Taccone P, Mascheroni D, Labarta V, et al. Effects of the prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 2001;345:568-73.
19. Messerole E, Peine P, Wittkopp S, Marini JJ, Albert RK. The pragmatics of prone positioning. Am J Respir Crit Care Med 2002;165:1359-63.
20. Kornecki A, Frndova H, Coates AL, Shemie SD. A randomized trial of prolonged prone positioning in children with acute respiratory failure. Chest 2001;119:211-8.
21. Ward NS. Effects of prone position ventilation in ARDS. An evidence-based review of the literature. Crit Care Clin 2002;18:35-44.
22. Curley MA, Thompson JE, Arnold JH. The effects of early and repeated prone positioning in pediatric patients with acute lung injury. Chest 2000;118:156-63.
23. Frerking I, Günther A, Seeger W, Pison U. Pulmonary surfactant Functions, abnormalities and therapeutic options. Int Care Med 2001;27:1699-717.
24. Evans DA, Wilmott RW, Whistt JA. Surfactant replacement therapy for adult respiratory distress syndrome in children. Pediatric Pulmonology 1996;21:328-36.
25. Anzueto A, Baughman RP, Guntupalli KK, Weg JG, Wiedemann HP, Raventos AA, et al. Aerolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 1996;334:1417-21.
26. Nakamura CT, Ripka JF, McVeigh K, Kapoor N, Keens TG. Bronchoscopic instillation of surfactant in acute respiratory distress syndrome. Pediatr Pulmonol 2001;31:317-20.
27. Stevens TP, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RSD. (Cochrane review). In: The Cochrane Library, Issue 3, 2002. Oxford: Update. sofware,
28. Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome: In: The Cochrane Library, Issue 3, 2002. Oxford: Update sofware.
29. Mclntyre RC Jr, Pulido EJ, Bensard DD, Shames BD, Abraham E. Thirty years of clinical trials in acute respiratory distress syndrome. Crit Care Med 2000;28:3314-31.
30. Soll RF, Dargaville P. Surfactante para el síndrome de aspiración de meconio en niños a término a termino. In: The Cochrane Library, 2, 2002. Oxford: Update sofware.
31. Willson DF, Zaritsky A, Bauman LA, Dockery K, James RL, Conrad D, et al. Instillation of calf's lung surfactant extract (Infasurf) is beneficial in pediatric acute hypoxemic respiratory failure. Crit Care Med 1999;27:188-95.